位置:首页 > 蛋白库 > YAP1_ORYLA
YAP1_ORYLA
ID   YAP1_ORYLA              Reviewed;         459 AA.
AC   H2LBU8;
DT   16-SEP-2015, integrated into UniProtKB/Swiss-Prot.
DT   16-SEP-2015, sequence version 2.
DT   25-MAY-2022, entry version 43.
DE   RecName: Full=Transcriptional coactivator YAP1 {ECO:0000250|UniProtKB:P46937};
DE            Short=Yes-associated protein 1 {ECO:0000250|UniProtKB:P46937};
DE   AltName: Full=Protein hirame {ECO:0000303|PubMed:25778702};
DE   AltName: Full=Protein yorkie homolog {ECO:0000250|UniProtKB:P46937};
DE   AltName: Full=Yes-associated protein YAP65 homolog {ECO:0000250|UniProtKB:P46937};
GN   Name=yap1 {ECO:0000250|UniProtKB:P46937};
GN   Synonyms=hir {ECO:0000303|PubMed:25778702};
OS   Oryzias latipes (Japanese rice fish) (Japanese killifish).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Neoteleostei; Acanthomorphata;
OC   Ovalentaria; Atherinomorphae; Beloniformes; Adrianichthyidae; Oryziinae;
OC   Oryzias.
OX   NCBI_TaxID=8090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Hd-rR;
RX   PubMed=17554307; DOI=10.1038/nature05846;
RA   Kasahara M., Naruse K., Sasaki S., Nakatani Y., Qu W., Ahsan B., Yamada T.,
RA   Nagayasu Y., Doi K., Kasai Y., Jindo T., Kobayashi D., Shimada A.,
RA   Toyoda A., Kuroki Y., Fujiyama A., Sasaki T., Shimizu A., Asakawa S.,
RA   Shimizu N., Hashimoto S., Yang J., Lee Y., Matsushima K., Sugano S.,
RA   Sakaizumi M., Narita T., Ohishi K., Haga S., Ohta F., Nomoto H., Nogata K.,
RA   Morishita T., Endo T., Shin-I T., Takeda H., Morishita S., Kohara Y.;
RT   "The medaka draft genome and insights into vertebrate genome evolution.";
RL   Nature 447:714-719(2007).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, PHOSPHORYLATION AT
RP   SER-21; SER-69; SER-87 AND SER-119, AND MUTAGENESIS OF SER-21; SER-69;
RP   SER-87 AND SER-119.
RX   PubMed=25778702; DOI=10.1038/nature14215;
RA   Porazinski S., Wang H., Asaoka Y., Behrndt M., Miyamoto T., Morita H.,
RA   Hata S., Sasaki T., Krens S.F., Osada Y., Asaka S., Momoi A., Linton S.,
RA   Miesfeld J.B., Link B.A., Senga T., Castillo-Morales A., Urrutia A.O.,
RA   Shimizu N., Nagase H., Matsuura S., Bagby S., Kondoh H., Nishina H.,
RA   Heisenberg C.P., Furutani-Seiki M.;
RT   "YAP is essential for tissue tension to ensure vertebrate 3D body shape.";
RL   Nature 521:217-221(2015).
CC   -!- FUNCTION: Transcriptional regulator which can act both as a coactivator
CC       and a corepressor and is the critical downstream regulatory target in
CC       the Hippo signaling pathway that plays a pivotal role in organ size
CC       control and tumor suppression by restricting proliferation and
CC       promoting apoptosis (By similarity). Plays a key role in tissue tension
CC       and 3D tissue shape by regulating cortical actomyosin network formation
CC       (PubMed:25778702). {ECO:0000250|UniProtKB:P46937,
CC       ECO:0000269|PubMed:25778702}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P46937}. Nucleus
CC       {ECO:0000250|UniProtKB:P46937}. Note=Both phosphorylation and cell
CC       density can regulate its subcellular localization. Phosphorylation
CC       sequesters it in the cytoplasm by inhibiting its translocation into the
CC       nucleus. At low density, predominantly nuclear and is translocated to
CC       the cytoplasm at high density. {ECO:0000250|UniProtKB:P46937}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed throughout development.
CC       {ECO:0000269|PubMed:25778702}.
CC   -!- PTM: Phosphorylated by lats1 and lats2; leading to cytoplasmic
CC       translocation and inactivation. {ECO:0000305|PubMed:25778702}.
CC   -!- DISRUPTION PHENOTYPE: Embryos are sensitive to deformation by gravity
CC       and display a markedly flattened body. Mutants show delayed blastopore
CC       closure and progressive body collapse from mid-neurulation, surviving
CC       until just before hatching (6 days post-fertilization, dpf). During
CC       body collapse, tissues and organs including neural tube and somites
CC       become gradually flattened and improperly aligned.
CC       {ECO:0000269|PubMed:25778702}.
CC   -!- SIMILARITY: Belongs to the YAP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; H2LBU8; -.
DR   SMR; H2LBU8; -.
DR   STRING; 8090.ENSORLP00000003377; -.
DR   iPTMnet; H2LBU8; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   HOGENOM; CLU_041917_0_1_1; -.
DR   InParanoid; H2LBU8; -.
DR   TreeFam; TF326941; -.
DR   Proteomes; UP000001038; Unplaced.
DR   Proteomes; UP000265180; Chromosome 9.
DR   Proteomes; UP000265200; Chromosome 9.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0035329; P:hippo signaling; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd00201; WW; 2.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   PROSITE; PS01159; WW_DOMAIN_1; 2.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Cytoplasm; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..459
FT                   /note="Transcriptional coactivator YAP1"
FT                   /id="PRO_0000433906"
FT   DOMAIN          126..159
FT                   /note="WW 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          186..219
FT                   /note="WW 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   REGION          51..88
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          103..129
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          231..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          247..459
FT                   /note="Transactivation domain"
FT                   /evidence="ECO:0000250|UniProtKB:P46937"
FT   REGION          307..364
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        103..118
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         21
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000305|PubMed:25778702"
FT   MOD_RES         69
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000305|PubMed:25778702"
FT   MOD_RES         87
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000305|PubMed:25778702"
FT   MOD_RES         119
FT                   /note="Phosphoserine; by LATS1 and LATS2"
FT                   /evidence="ECO:0000305|PubMed:25778702"
FT   MUTAGEN         21
FT                   /note="S->A: In YAP-4SA; prevents phosphorylation by LATS1
FT                   and LATS2, promoting retention in the nucleus; when
FT                   associated with A-69; A-87 and A-119."
FT                   /evidence="ECO:0000269|PubMed:25778702"
FT   MUTAGEN         69
FT                   /note="S->A: In YAP-4SA; prevents phosphorylation by LATS1
FT                   and LATS2, promoting retention in the nucleus; when
FT                   associated with A-21; A-87 and A-119."
FT                   /evidence="ECO:0000269|PubMed:25778702"
FT   MUTAGEN         87
FT                   /note="S->A: In YAP-4SA; prevents phosphorylation by LATS1
FT                   and LATS2, promoting retention in the nucleus; when
FT                   associated with A-21; A-87 and A-119."
FT                   /evidence="ECO:0000269|PubMed:25778702"
FT   MUTAGEN         119
FT                   /note="S->A: In YAP-4SA; prevents phosphorylation by LATS1
FT                   and LATS2, promoting retention in the nucleus; when
FT                   associated with A-21; A-69 and A-87."
FT                   /evidence="ECO:0000269|PubMed:25778702"
SQ   SEQUENCE   459 AA;  50053 MW;  B9C11A29AD51D512 CRC64;
     MDPSQHNPPV GHQIVHVRGD SETDLEALFN AVMNPKGAVV PQSVPMRMRK LPDSFFKPPE
     PKSHSRQAST DAGSGGVLTP HHVRAHSSPA SLQLGAVSGG SLSGMASAGA SPQHLRQSSY
     EIPDDVPLPP GWEMAKTSSG QRYFLNHIDQ TTTWQDPRKA LLQLNQATPP STVPVQQQNL
     LSPASGPLPE GWEQAITPEG EIYYINHKNK TTSWLDPRLE TRYALNQQRI TQSAPVKQGG
     PLPPNPHGGV MGGNNQMRLQ QMEKERIRLK QQELLRQSQR PQIDLQPSTA NQDAEHCDEL
     ALRNQLPTSM DQDGSSNPVS SPMAQDARTM TANSNDPFLN SVSSGTYHSR DESTDSGLSM
     SSYSVPRTPD DFLNSVDEMD TGDPLAPSMA TQPSRFPDYL DTIPGTDVDL GTLEGESMAV
     EGEELMPSLQ EALSSDILND MESVLAATKI DKESFLTWL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024